Showing results (991-1000 of 1,050) with videos related to
Sort By:
Pageof 105
Oncotarget|October 31, 2015
A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinomaShan-Shan Jiang, Yan Tang, Yao-Jun Zhang, et al.Journal of Long-Term Effects of Medical Implants|November 1, 2006
Avian Flu pandemic in the United States. The Sanitec Industry's solutionRichard F Edlich, Lise Borel, H Gordon Jensen, et al.BMC Cancer|March 2, 2019
Primary paediatric epidural sarcomas: molecular exploration of three casesSharon Y Y Low, Chik Hong Kuick, Wan Yi Seow, et al.The American Journal of Managed Care|March 15, 2021
The essential role of population health during and beyond COVID-19Salina Bakshi, Katherine H Schiavoni, Lucas C Carlson, et al.Oncogene|August 1, 2017
EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasisC-H Shih, Y-J Chang, W-C Huang, et al.Journal of Long-Term Effects of Medical Implants|March 29, 2006
Revolutionary advances in medical waste management. The Sanitec systemRichard F Edlich, Lise Borel, H Gordon Jensen, et al.Nuclear Medicine and Biology|June 10, 1998
Immunolymphoscintigraphy in breast cancer: evaluation using 131I-labeled monoclonal antibody B72.3L M Fig, R S Brown, L von Moll, et al.Nano Letters|September 14, 2020
Cancer Immunotherapy via Targeting Cancer Stem Cells Using Vaccine NanodiscsAlireza Hassani Najafabadi, Jing Zhang, Marisa E Aikins, et al.American Journal of Hematology|December 15, 2015
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908)Clive S Zent, Xin Victoria Wang, Rhett P Ketterling, et al.Blood|July 28, 2018
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PETDavid J Straus, Sin-Ho Jung, Brandelyn Pitcher, et al.Pageof 105